80 related articles for article (PubMed ID: 6438647)
1. In vitro inhibition of the human malaria parasite by selected lipophilic chelators.
Scheibel LW
Prog Clin Biol Res; 1984; 165():377-94. PubMed ID: 6438647
[No Abstract] [Full Text] [Related]
2. Antimalarial activity of selected aromatic chelators. II. Substituted quinolines and quinoline-N-oxides.
Scheibel LW; Adler A
Mol Pharmacol; 1981 Jul; 20(1):218-23. PubMed ID: 6793844
[No Abstract] [Full Text] [Related]
3. Antimalarial activity of selected aromatic chelators. III. 8-Hydroxyquinolines (oxines) substituted in positions 5 and 7, and oxines annelated in position 5,6 by an aromatic ring.
Scheibel LW; Adler A
Mol Pharmacol; 1982 Jul; 22(1):140-4. PubMed ID: 6811856
[No Abstract] [Full Text] [Related]
4. Antimalarial activity of selected aromatic chelators.
Scheibel LW; Adler A
Mol Pharmacol; 1980 Sep; 18(2):320-5. PubMed ID: 6775184
[No Abstract] [Full Text] [Related]
5. Antimalarial activity of selected aromatic chelators V. Localization of 59Fe in Plasmodium falciparum in the presence of oxines.
Scheibel LW; Rodriguez S
Prog Clin Biol Res; 1989; 313():119-49. PubMed ID: 2506579
[No Abstract] [Full Text] [Related]
6. Malaria: Hitting all stages of the parasite life cycle.
Flemming A
Nat Rev Drug Discov; 2015 Aug; 14(8):527. PubMed ID: 26205463
[No Abstract] [Full Text] [Related]
7. Malaria: Hitting all stages of the parasite life cycle.
Flemming A
Nat Rev Microbiol; 2015 Aug; 13(8):458. PubMed ID: 26179353
[No Abstract] [Full Text] [Related]
8. Antimalarial activity of the novel quinoline/6-thiopurine conjugate in Gallus gallus Linnaeus, infected experimentally by Plasmodium (Novyella) juxtanucleare.
Vashist U; Carvalhaes R; D'agosto M; da Silva AD
Chem Biol Drug Des; 2009 Oct; 74(4):434-7. PubMed ID: 19691466
[TBL] [Abstract][Full Text] [Related]
9. Plasmodium chabaudi-infection of mice: effects of chloroquine and mefloquine. Inhibition of ornithine decarboxylase activity.
Königk E; Mirtsch S; Putfarken B; Abdel-Rasoul S
Tropenmed Parasitol; 1981 Jun; 32(2):73-6. PubMed ID: 6973226
[TBL] [Abstract][Full Text] [Related]
10. 2-Oxotetrahydroquinoline-based antimalarials with high potency and metabolic stability.
Bulbule VJ; Rivas K; Verlinde CL; Van Voorhis WC; Gelb MH
J Med Chem; 2008 Feb; 51(3):384-7. PubMed ID: 18198825
[TBL] [Abstract][Full Text] [Related]
11. Bisquinolines. 2. Antimalarial N,N-bis(7-chloroquinolin-4-yl)heteroalkanediamines.
Vennerstrom JL; Ager AL; Dorn A; Andersen SL; Gerena L; Ridley RG; Milhous WK
J Med Chem; 1998 Oct; 41(22):4360-4. PubMed ID: 9784111
[TBL] [Abstract][Full Text] [Related]
12. The design of original antimalarial drugs. An example of phospholipid metabolism.
Vial HJ; Ancelin ML; Elabbadi N; Gumila C; Bonnet H; Jeong YH; Philippot J; Calas M; Portefaix P; Piquet G
Parassitologia; 1993 Jul; 35 Suppl():125-7. PubMed ID: 8233602
[TBL] [Abstract][Full Text] [Related]
13. Heme metabolism of Plasmodium is a major antimalarial target.
Padmanaban G; Rangarajan PN
Biochem Biophys Res Commun; 2000 Feb; 268(3):665-8. PubMed ID: 10679261
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity relationship of anti-malarial spongean peroxides having a 3-methoxy-1,2-dioxane structure.
Kawanishi M; Kotoku N; Itagaki S; Horii T; Kobayashi M
Bioorg Med Chem; 2004 Oct; 12(20):5297-307. PubMed ID: 15388157
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and antimalarial activity of carbamate and amide derivatives of 4-anilinoquinoline.
Delarue-Cochin S; Grellier P; Maes L; Mouray E; Sergheraert C; Melnyk P
Eur J Med Chem; 2008 Oct; 43(10):2045-55. PubMed ID: 18226428
[TBL] [Abstract][Full Text] [Related]
16. Resistance to antimalarial compounds: methods and applications.
Witkowski B; Berry A; Benoit-Vical F
Drug Resist Updat; 2009; 12(1-2):42-50. PubMed ID: 19285915
[TBL] [Abstract][Full Text] [Related]
17. Antimalarial effects of C18 fatty acids on Plasmodium falciparum in culture and on Plasmodium vinckei petteri and Plasmodium yoelii nigeriensis in vivo.
Krugliak M; Deharo E; Shalmiev G; Sauvain M; Moretti C; Ginsburg H
Exp Parasitol; 1995 Aug; 81(1):97-105. PubMed ID: 7628573
[TBL] [Abstract][Full Text] [Related]
18. Novel molecular targets for antimalarial drug development.
Sahu NK; Sahu S; Kohli DV
Chem Biol Drug Des; 2008 Apr; 71(4):287-97. PubMed ID: 18298458
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and in vitro and in vivo antimalarial activity of N1-(7-chloro-4-quinolyl)-1,4-bis(3-aminopropyl)piperazine derivatives.
Ryckebusch A; Deprez-Poulain R; Maes L; Debreu-Fontaine MA; Mouray E; Grellier P; Sergheraert C
J Med Chem; 2003 Feb; 46(4):542-57. PubMed ID: 12570376
[TBL] [Abstract][Full Text] [Related]
20. [The Plasmodium digestive vacuole: an antimalarial target].
Zhai ZL; Wu WP
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2001; 19(6):363-6. PubMed ID: 12572075
[No Abstract] [Full Text] [Related]
[Next] [New Search]
